Cas:188064-15-5 (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one manufacturer & supplier

Chemical Name:(3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one

CAS.NO:188064-15-5

Synonyms:(3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one

Molecular Formula:C₁₁H₁₀O₂

Molecular Weight:174.19600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:26.30000

Exact Mass:174.06800

LogP:1.84690

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one Use and application,(3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one technical grade,usp/ep/jp grade.

Related News: This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one manufacturer The mode of cooperation between domestic API companies and large international companies can lower the export threshold. (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one vendor Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. (3aR,8bS)-3,3a,4,8b-Tetrahydro-2H-indeno[1,2-b]furan-2-one factory This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.